Francesca Finotello

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Mitochondrial Dna

Top Venues

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

Nature biotechnology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Isaac Virshup, Danila Bredikhin, Lukas Heumos, Giovanni Palla, Gregor Sturm, Adam Gayoso, Ilia Kats, Mikaela Koutrouli, null null, Bonnie Berger, Dana Pe'er, Aviv Regev, Sarah A Teichmann, Francesca Finotello, F Alexander Wolf, Nir Yosef, Oliver Stegle, Fabian Joachim Theis
The scverse project provides a computational ecosystem for single-cell omics data analysis. Nature biotechnology (2023)
Ziena Abdulrahman, Saskia J A M Santegoets, Gregor Sturm, Pornpimol Charoentong, Marieke E Ijsselsteijn, Antonios Somarakis, Thomas Höllt, Francesca Finotello, Zlatko Trajanoski, Sylvia L van Egmond, Dana A M Mustafa, Marij J P Welters, Noel F C C de Miranda, Sjoerd H Van der Burg
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival. Journal for immunotherapy of cancer 10 (2) (2022)
Chantal L Duurland, Saskia J A M Santegoets, Ziena Abdulrahman, Nikki M Loof, Gregor Sturm, Tom H Wesselink, Ramon Arens, Sanne Boekestijn, Ilina Ehsan, Mariette I E van Poelgeest, Francesca Finotello, Hubert Hackl, Zlatko Trajanoski, Peter Ten Dijke, Veronique M Braud, Marij J P Welters, Sjoerd H Van der Burg
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors. Journal for immunotherapy of cancer 10 (1) (2022)
Kim E Kortekaas, Saskia J Santegoets, Gregor Sturm, Ilina Ehsan, Sylvia L van Egmond, Francesca Finotello, Zlatko Trajanoski, Marij J P Welters, Mariette I E van Poelgeest, Sjoerd H Van der Burg
CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer. Cancer immunology research 8 (10) (2020)
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buque, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro-Manzano, Francisco Ayala, Elena García-Martínez, Silvia C Formenti, Zlatko Trajanoski, Lorenzo Galluzzi
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology 21 (10) (2020)
Anna Maria Di Giacomo, Alessia Covre, Francesca Finotello, Dietmar Rieder, Riccardo Danielli, Luca Sigalotti, Diana Giannarelli, Florent Petitprez, Laetitia Lacroix, Monica Valente, Ornella Cutaia, Carolina Fazio, Giovanni Amato, Andrea Lazzeri, Santa Monterisi, Clelia Miracco, Sandra Coral, Andrea Anichini, Christoph Bock, Amelie Nemc, Aram Oganesian, James Lowder, Mohammad Azab, Catherine Sautès-Fridman, Zlatko Trajanoski, Michele Maio
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)
Francesca Finotello, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski
Next-generation computational tools for interrogating cancer immunity. Nature reviews. Genetics 20 (12) (2019)
Mirjana Efremova, Dietmar Rieder, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Hubert Hackl, Natascha Hermann-Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam, Zlatko Trajanoski
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nature communications 9 (1) (2018)
Francesca Finotello, Zlatko Trajanoski
Quantifying tumor-infiltrating immune cells from transcriptomics data. Cancer immunology, immunotherapy : CII 67 (7) (2018)
Nataliya Rohr-Udilova, Florian Klinglmüller, Rolf Schulte-Hermann, Judith Stift, Merima Herac, Martina Salzmann, Francesca Finotello, Gerald Timelthaler, Georg Oberhuber, Matthias Pinter, Thomas Reiberger, Erika Jensen-Jarolim, Robert Eferl, Michael Trauner
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Scientific reports 8 (1) (2018)